Indaptus Therapeutics, Inc. Liquidation Value
INDP
Other
Cash & Equivalents
$8.51M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $8.51M
Total Obligations: -$6.16M
$2.35M
Per share: $1.08
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $8.51M
AR: $0
Total Obligations: -$6.16M
$2.35M
Per share: $1.08
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $8.51M
AR: $0
Inventory: $0
Total Obligations: -$6.16M
$2.35M
Per share: $1.08
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $2.35M | $1.08 |
| Liquid Liquidation Value | $2.35M | $1.08 |
| Operating Liquidation Value | $2.35M | $1.08 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $8.51M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $6.16M |
| Long-term Debt | $6.50M |
| Op. Lease Liability | $8,686 |
| Finance Lease | N/A |
| Shares Outstanding | 2.2M |
Explore all 101 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $8.51M | N/A | N/A | $544,057 | $6.16M | N/A | N/A | N/A |
| 2025-09-30 | $5.83M | N/A | N/A | $707,420 | $2.23M | N/A | $8,686 | N/A |
| 2025-07-27 | N/A | N/A | N/A | N/A | N/A | $6.80M | N/A | N/A |
| 2025-06-30 | $6.16M | N/A | N/A | $618,515 | $8.51M | $6.50M | $34,373 | N/A |
| 2025-03-31 | $3.89M | N/A | N/A | $1.31M | $2.61M | N/A | $59,512 | N/A |
| 2024-12-31 | $5.79M | N/A | N/A | $870,229 | $3.39M | N/A | $84,164 | N/A |
| 2024-09-30 | $7.38M | N/A | N/A | $555,949 | $2.23M | N/A | $107,989 | N/A |
| 2024-06-30 | $7.30M | N/A | N/A | $416,555 | $1.93M | N/A | $130,802 | N/A |
▼ Community Notes